Fatal Spitz Melanoma With MAD1L1::BRAF Fusion: A Case Report and Literature Review
Journal of Cutaneous Pathology · 2025
DOI: 10.1111/cup.14779 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2025. Verfasst von Tsubasa Hiraki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Nevus, Epithelioid and Spindle Cell, Skin Neoplasms, Melanoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Spitz melanoma is extremely rare, and only a few cases of distant metastases have been reported. Herein, we describe a case of Spitz melanoma with multiple distant metastases. A 37‐year‐old woman presented with a 5.5‐mm‐diameter nodule on the right lower leg. She experienced multiple distant metastases, involving the lungs, liver, thyroid, stomach, ovary, bones, and skin, along with multiple lymph node metastases within 1 year. The patient succumbed to the disease 1 year and 6 months following the first excision. Histopathological examination revealed a dense distribution of large solid nests comprising large, atypical epithelioid melanocytes with abundant eosinophilic cytoplasm in the upper dermis. Diffuse PRAME and loss of p16 immunoexpression profiles were observed. Targeted DNA and Sanger sequencing revealed an in‐frame MAD1L1 (e16) ::BRAF (e9) fusion in both primary tumor and metastatic subcutaneous lesion. A review of previously reported cases confirmed as Spitz melanoma with distant metastases ( n = 7) revealed a broad age range (11–71 years, median 46 years), high mortality (5/7), frequent BRAF fusions (6/7), and recurrent TERT promotor mutations and CDKN2A/B deletions. This report adds valuable insights into our understanding of the clinical and genetic characteristics of Spitz melanoma with distant metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, Shizuoka Cancer Center Hospital, Sunto, Japan.
- Department of Supportive Care in Cancer, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
- Department of Pathology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
- Department of Diagnostic Pathology, Hyogo Cancer Center, Akashi, Japan.
- Department of Pathology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan.
- Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan.
ORCID-Profile: Satoshi Hirakawa, Yoshiro Otsuki, Keisuke Goto
Förderung
- JSPS KAKENHI
Zitieren
APA
Hiraki, T., Hirakawa, S., Otsuki, Y., Kajimoto, K., Goto, K., & Serizawa, M. (2025). Fatal Spitz Melanoma With MAD1L1::BRAF Fusion: A Case Report and Literature Review. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14779
Vancouver
Hiraki T, Hirakawa S, Otsuki Y, Kajimoto K, Goto K, Serizawa M. Fatal Spitz Melanoma With MAD1L1::BRAF Fusion: A Case Report and Literature Review. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.14779
BibTeX
@article{Hiraki2025,
author = {Hiraki, Tsubasa and Hirakawa, Satoshi and Otsuki, Yoshiro and Kajimoto, Kazuyoshi and Goto, Keisuke and Serizawa, Masakuni},
title = {Fatal Spitz Melanoma With MAD1L1::BRAF Fusion: A Case Report and Literature Review},
journal = {Journal of Cutaneous Pathology},
year = {2025},
doi = {10.1111/cup.14779}
}
EUVIMED